Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Zeria Pharmaceutical produces veterinary pharmaceuticals, agricultural chemicals, industrial chemicals and reagents, and more. In addition, they also provide cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and more.

Jina Pharmaceuticals is a clinical research company that develops and commercialize novel therapeutic products for various treatments.

Curacle Co., Ltd. is engaged in the business of research and experimental development on medical sciences and pharmacy. It develops drugs for diabetes and stroke. The company was founded by Yeong-Geun, Kwon on May 12, 2016 and is headquartered in Seongnam-si, South Korea.

Disphar International offers generic and value-added pharmaceutical products and development, licensing out of pharmaceutical products.

CP Pharmaceutical (Qingdao) Co., Ltd., established on 1994-11-24, Business scope includes licensed projects:Production:soft capsule(Contains antineoplastic drugs),tablet,Granules,hard capsule,mixture,oral solution,small volume injection,API,Freeze-dried powder injection;Production,Sales:Healthy food"Caili Oral Liquid",medical instruments(Pharmaceutical Production License,The validity period of the food hygiene license is subject to the license);General project:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Adamed Sp zoo manufactured pharmaceutical products. It offered prescription drugs, non-prescription products, and dermocosmetics. The company was founded by Marian Adamkiewicz in 1986 and was headquartered in Czosnow, Poland.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Yangzhou Yiyang Pharmaceutical Co., Ltd., established on 2002-02-10, The scope of business includes the production of powder injections,tablet,Suspension;Sell ​​the company's own products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pharmasset Inc is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Their primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus, or HBV, hepatitis C virus, or HCV and human immunodeficiency virus, or HIV. Their research and development efforts focus on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication. They are currently focusing on three product candidates, two of which they are developing themselves and one of which they are developing with a strategic partner: • Clevudine, for the treatment of HBV, expected to enter Phase 3 registration clinical trials in the second calendar quarter of 2007; • R7128, a pro-drug of PSI-6130 for the treatment of HCV, in a Phase 1 clinical trial; and • Racivir, for the treatment of HIV, in a Phase 2 clinical trial.

Manufactures, marketes and imports, exports pharmaceutical drugs

Beijing Shuguang Pharmaceutical Co., Ltd., established on 1979-11-10, Business scope includes manufacturing,Processing powder,Capsules,tablet,tincture,ointment,Granules(Carry out production in different places according to law);General cargo;Operate the self-produced products and technology export business of the enterprise and its member enterprises,Raw and auxiliary materials required for the production of the enterprise and member enterprises,Instrumentation,Equipment,Import business of spare parts and technology(The state restricts the operation of the company and the state prohibits the import and export of goods except);operating incoming material processing and"Three to one make up"business.(Except for projects without special approval.;Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on December 14, 1995 and is headquartered in Linyi, China.

Established in 1987, Korea United Pharm. Inc. has continued to develop as a pharmaceutical company with its slogan of "Korean owned multinational pharmaceutical company." We have continuously launched new pharmaceutical drugs such as Cilostan CR Tab, Gastiin CR Tab, Clanza CR Tab and etc., through prestigious R&D investment, abundant know-hows and top expert researchers and have been placed as a strong competitor in the pharmaceutical drug development industry. they were named one of Asia's 200 most promising companies by the US economy magazine Forbes.

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan.

Sinotherapeutics, Inc. engages in the research and development, production and sales of high-end generic drugs and Contract Research Organization (CRO) services. Its CRO services include generics-brand product consistency evaluation services, research and development of 505B2 products, formulation development services, regulatory registration filing services, and cGMP production. The company was founded on August 13, 2012 and is headquartered in Shanghai, China.

Chongqing Duoputai Pharmaceutical Co., Ltd. manufactures and sales drugs. The company’s main products are Maixuekang capsules, Maixuekang tablets, and Ruomaixuekang series products. The company was founded on March 29, 2004 and is headquartered in Chongqing, China.

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.